Patent Assignment
Reel/Frame 075267/0816
Release of Security Interest
Recorded: 2026-07-14
Pages: 6
Assignor
GLAS AMERICAS LLC
Executed: 2026-07-13
Assignee
ESPERION THERAPEUTICS INC.
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MICHIGAN, 48108
Covered Properties
(25)
Methods of Making Bempedoic Acid and Compositions of the Same
Methods of Making Bempedoic Acid and Compositions of the Same
Application:
18/632,996 →
Publication:
US 2024/0286987
Salt Forms of Bempedoic Acid and Methods for Using the Same
Compositions Containing and Therapies Using Bempedoic Acid and Tolvaptan
Application:
18/565,762 →
Publication:
US 2024/0366625
Macrocyclic Inhibitors of Atp Citrate Lyase
Application:
18/862,295 →
Publication:
US 2025/0289793
Methods of Making Bempedoic Acid and Compositions of the Same
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application:
18/601,088 →
Publication:
US 2024/0398746
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application:
18/949,376 →
Publication:
US 2025/0064767
Pharmaceutical Compositions Comprising Granulated Bempedoic Acid
Application:
17/720,625 →
Publication:
US 2022/0249380
Methods for Reducing the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Illnesses
Application:
17/271,045 →
Publication:
US 2021/0322376
Dihydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Methods of Making Bempedoic Acid and Compositions of the Same
Methods of Making Bempedoic Acid and Compositions of the Same
Methods of Making Bempedoic Acid and Compositions of the Same
Methods of Making Bempedoic Acid and Compositions of the Same
Methods of Making Bempedoic Acid and Compositions of the Same
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing Cardiovascular Disease
Methods of Treatment Using Bempedoic Acid
PCT:
PCT/US2023/061334 ↗
Methods of Treatment Using Bempedoic Acid
PCT:
PCT/US2024/010673 ↗
Compositions Containing, and Combination Therapies Using Bempedoic Acid and a Glp-1 Receptor Agonist
PCT:
PCT/US2024/036741 ↗
Macrocyclic Inhibitors of Atp Citrate Lyase
PCT:
PCT/US2024/053844 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 7, 2004
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 015431/0357 →
Assignment of Assignor's Interest
Nov 1, 2004
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 015945/0158 →
Assignment of Assignor's Interest
Oct 14, 2014
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033943/0751 →
Merger
Oct 14, 2014
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033946/0330 →
Security Interest
Jun 28, 2019
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 049623/0629 →
Assignment of Assignor's Interest
Oct 25, 2019
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050823/0885 →
Security Interest
Apr 26, 2021
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 056044/0988 →
Assignment of Assignor's Interest
Jun 13, 2022
From: COPP, RICHARD; CIMARUSTI, CHRISTOPHER M.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0094 →
Assignment of Assignor's Interest
Jun 13, 2022
From: LANE, JONATHAN; BARKMAN, MICHAEL; AMIN, RASIDUL; FRANK, MICHELLE
To: CORDEN PHARMA COLORADO, INC.
Reel/Frame 060183/0076 →
Assignment of Assignor's Interest
Jun 13, 2022
From: CORDEN PHARMA COLORADO, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0088 →
Assignment of Assignor's Interest
Jun 13, 2022
From: PATHEON AUSTRIA GMBH & CO KG
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0170 →
Assignment of Assignor's Interest
Jun 13, 2022
From: OLON RICERCA BIOSCIENCE LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0159 →
Assignment of Assignor's Interest
Jun 13, 2022
From: COOPER, ARTHUR JOHN; GOPAL, DAMODARAGOUNDER
To: OLON RICERCA BIOSCIENCE LLC
Reel/Frame 060183/0147 →
Assignment of Assignor's Interest
Jun 13, 2022
From: SELIG, PHILIPP
To: PATHEON AUSTRIA GMBH & CO KG.
Reel/Frame 060183/0121 →
Assignment of Assignor's Interest
Jan 8, 2024
From: CORDEN PHARMA COLORADO, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0570 →
Assignment of Assignor's Interest
Jan 8, 2024
From: COOPER, ARTHUR JOHN; GOPAL, DAMODARAGOUNDER
To: OLON RICERCA BIOSCIENCE LLC
Reel/Frame 066048/0576 →
Assignment of Assignor's Interest
Jan 8, 2024
From: OLON RICERCA BIOSCIENCE LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0583 →
Assignment of Assignor's Interest
Jan 8, 2024
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0362 →
Assignment of Assignor's Interest
Jan 8, 2024
From: COPP, RICHARD; CIMARUSTI, CHRISTOPHER M.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0513 →
Assignment of Assignor's Interest
Jan 8, 2024
From: SELIG, PHILIPP
To: PATHEON AUSTRIA GMBH & CO KG
Reel/Frame 066048/0529 →
Assignment of Assignor's Interest
Jan 8, 2024
From: PATHEON AUSTRIA GMBH & CO KG
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0540 →
Assignment of Assignor's Interest
Jan 8, 2024
From: LANE, JONATHAN; BARKMAN, MICHAEL; AMIN, RASIDUL; FRANK, MICHELLE
To: CORDEN PHARMA COLORADO, INC.
Reel/Frame 066048/0561 →
Release of Security Interest
Jun 27, 2024
From: EIGER III SA LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 067963/0094 →
Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement
Jul 19, 2024
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 068459/0136 →
Security Interest
Dec 13, 2024
From: ESPERION THERAPEUTICS, INC.
To: GLAS AMERICAS LLC
Reel/Frame 069582/0756 →